We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




A Unique Streptococcus Strain Now Dominates the Infection Landscape in the United Kingdom

By LabMedica International staff writers
Posted on 04 Aug 2015
British microbiologists have identified the mutations that were responsible for the dramatic increase in virulence of a Group A Streptococcus (GAS) variant that has now emerged as the dominant strain in the United Kingdom.

Investigators at Imperial College London (United Kingdom) used whole-genome sequencing techniques to analyze changes in the genome of GAS genotype emm89. More...
A sharp rise in the number of infections caused by this particular strain was observed from 1998 to 2009.

Results of whole-genome sequencing revealed that although standard variable typing regions (emm subtype, tee type, sof type, and multilocus sequence typing [MLST]) remained unchanged, this unique subtype had undergone six distinct regions of homologous recombination across the genome compared to the rest of the sequenced emm89 population. Two of these regions affected known virulence factors, the hyaluronic acid capsule and the toxins NADase and streptolysin O.

Loss of the hyaluronic acid capsule was a particularly surprising finding, as it had been believed by microbiologists that the capsule was essential for GAS bacteria to cause invasive disease.

Senior author Dr. Shiranee Sriskandan, professor of medicine at Imperial College London, said, "This discovery was made possible thanks to the cooperation of our hospital diagnostic lab and the national reference lab, which helped us to spot a pattern locally and then study it nationally. We know very little about how group A Streptococcus is transmitted from person to person. We need to look into this more deeply and think about better ways to prevent transmission. Luckily, the new variant remains exquisitely sensitive to penicillin and related antibiotics. But we also need to think about whether our treatment strategies are as good as they can be."

The work was published in the July 14, 2015, online edition of the journal mBio.

Related Links:

Imperial College London



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.